 LENALIDOMIDE AS MAINTENANCE THERAPY AFTER COMBINATION CHEMOTHERAPY WITH OR WITHOUT RITUXIMAB AND STEM CELL TRANSPLANT IN TREATING PATIENTS WITH PERSISTENT OR RECURRENT NON-HODGKIN LYMPHOMA THAT IS RESISTANT TO CHEMOTHERAPY: 